Contrave, A New Weight Loss Pill Combines Anti-Addiction Medication And An Antidepressant

Contrave, A New Weight Loss Pill Combines Anti-Addiction Medication And An Antidepressant.


An superb consultive panel recommended on Tuesday that Contrave, a changed weight-loss pilule that combines an antidepressant with an anti-addiction medication, be approved by the US Food and Drug Administration. The 13-7 choose in favor of Contrave came surrounded by instrumentality concerns that the dope might put forward blood pressure in some patients and broaden the risk of heart attacks and strokes mid some users, according to the Associated Press side effects of r41. But panelists voted 11-8 earlier in the period that those future health risks could be studied after Contrave was approved.



The FDA does not have to follow the news of its advisory committees, but it typically does. The operation is expected to give rise to a decision on Contrave by Jan 31, 2011, the wire use reported. contrave is manufactured by orexigen therapeutics inc. In October, the FDA voted against approving two other weight-loss drugs, Arena Pharmaceuticals' lorcaserin and Vivus' Qnexa, because of protection concerns, according to the AP in house pharmacy cart. Last July, a cram funded by Orexigen and published in The Lancet found that Contrave helped users pour pounds when entranced along with a shape parliament and exercise.



People who took the medicate for more than a year helpless an run-of-the-mill of 5 percent or more of body weight, depending on the administer used, the team said. However, the regimen did come with string effects, and about half of exploration participants dropped out before completing a year of treatment. Contrave is mixture of two famed drugs, naltrexone (Revia, used to exchange blows addictions) and the antidepressant bupropion (known by a army of names, including Wellbutrin).



The drug appears to raise weight loss by changing the workings of the body's key nervous system, the researchers said. The haunt enrolled men (15 percent) and women (85 percent) from around the country, ranging in long time from 18 to 65. They were all either rotund or overweightm, with tipsy blood fertility levels or high blood pressure.